Hims & Hers Health, Inc.
HIMS
54 insider filings · Latest: Jun 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | Jun 18 7:02 PM | Carroll Patrick Harrison | Proposed Sale | 23,726 | $35.00 | $830.4K | — | View → |
| Jun 17, 2026 | Jun 17 10:50 PM | Michael ChiChief Operating Officer | Sale | 14,027 | $31.50 | $441.9K | 432,124(D) | View → |
| Jun 17, 2026 | Jun 17 10:50 PM | Irene BecklundPAO | Sale | 4,490 | $31.50 | $141.4K | 6,790(D) | View → |
| Jun 16, 2026 | Jun 17 10:50 PM | Irene BecklundPAO | Sale | 7,573 | $30.25 | $229.1K | 11,280(D) | View → |
| Jun 17, 2026 | Jun 17 10:50 PM | Mohamed ElshenawyCTO | Sale | 30,040 | $31.50 | $946.3K | 101,023(D) | View → |
| Jun 17, 2026 | Jun 17 3:17 PM | Becklund Irene | Proposed Sale | 4,490 | $31.50 | $141.4K | — | View → |
| Jun 17, 2026 | Jun 17 3:10 PM | Elshenawy Mohamed | Proposed Sale | 30,040 | $31.50 | $946.3K | — | View → |
| Jun 17, 2026 | Jun 17 1:47 PM | Chi Michael | Proposed Sale | 14,027 | $31.50 | $441.9K | — | View → |
| Jun 16, 2026 | Jun 16 3:21 PM | Becklund Irene | Proposed Sale | 7,573 | $30.25 | $229.1K | — | View → |
| May 26, 2026 | May 26 8:48 PM | David B WellsDirector | Purchase | 48,400 | $24.24 | $1.2M | 224,417(D) | View → |
| May 18, 2026 | May 19 11:39 PM | Oluyemi OkupeChief Financial Officer | Sale | 7,950 | $23.64 | $187.9K | 262,954(D) | View → |
| Apr 20, 2026 | Apr 22 9:24 PM | Soleil BoughtonChief Legal Officer | Sale | 9,463 | $30.00 | $283.9K | 299,368(D) | View → |
| Apr 20, 2026 | Apr 22 9:24 PM | Oluyemi OkupeChief Financial Officer | Sale | 19,645 | $29.96 | $588.6K | 262,954(D) | View → |
| Apr 17, 2026 | Apr 20 8:38 PM | Oluyemi OkupeChief Financial Officer | Sale | 18,005 | $27.83 | $501.2K | 270,046(D) | View → |
| Apr 16, 2026 | Apr 20 8:38 PM | Oluyemi OkupeChief Financial Officer | Sale | 36,922 | $25.90 | $956.1K | 281,867(D) | View → |
| Apr 20, 2026 | Apr 20 5:19 PM | Boughton Soleil | Proposed Sale | 9,463 | $30.00 | $283.9K | — | View → |
| Apr 6, 2026 | Apr 7 9:14 PM | Oluyemi OkupeChief Financial Officer | Sale | 3,975 | $19.98 | $79.4K | 318,789(D) | View → |
| Apr 6, 2026 | Apr 6 10:03 PM | Oluyemi Okupe | Proposed Sale | 240,560 | $20.33 | $4.9M | — | View → |
| Mar 20, 2026 | Mar 24 10:09 PM | Oluyemi OkupeChief Financial Officer | Sale | 9,217 | $23.77 | $219.1K | 318,789(D) | View → |
| Mar 17, 2026 | Mar 18 8:17 PM | Irene BecklundPAO | Sale | 5,529 | $24.69 | $136.5K | 8,752(D) | View → |
Page 1 of 9
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Mar 13 8:20 PM | Patrick Harrison CarrollDirector, Chief Medical Officer | Grant/Award | 150,489 | — | 150,489(D) | View → |
| Mar 11, 2026 | Mar 13 8:20 PM | Soleil BoughtonChief Legal Officer | Grant/Award | 188,111 | — | 188,111(D) | View → |
| Mar 11, 2026 | Mar 13 8:20 PM | Mohamed ElshenawyCTO | Grant/Award | 376,222 | — | 376,222(D) | View → |
| Mar 11, 2026 | Mar 13 8:20 PM | Andrew DudumDirector, Chief Executive Officer, 10% Owner | Grant/Award | 413,844 | — | 413,844(D) | View → |
| Mar 11, 2026 | Mar 13 8:20 PM | Oluyemi OkupeChief Financial Officer | Grant/Award | 300,978 | — | 300,978(D) | View → |
| Feb 3, 2026 | Feb 4 9:13 PM | Oluyemi OkupeChief Financial Officer | Option Exercise | 5,262 | $5.01 | 144,051(D) | View → |
| Jan 20, 2026 | Jan 21 9:23 PM | Oluyemi OkupeChief Financial Officer | Option Exercise | 9,067 | $11.53 | 42,996(D) | View → |
← Previous
Page 3 of 3